Corona Update 21 April - Bert Hubert's writings
2 days ago
- The Netherlands successfully kept IC capacity within limits by following strict rules, but healthcare workers need rest.
- Rapid home tests were unreliable; several countries wasted millions on them. Reliable antibody tests show 3% of Dutch blood donors had antibodies in early April.
- Large-scale trials are underway for treatments like the TBC vaccine, Camostat Mesylate, and Remdesivir, with early positive results.
- Vaccines are still 18 months away, but could be prioritized for high-risk groups. Weather may help slightly but is not proven to be decisive.
- Test capacity in the Netherlands is now sufficient, but logistics and organization remain bottlenecks. Testing is currently limited to severe cases and medical staff.
- Contact tracing is crucial for controlling the epidemic; apps and manual tracing need support. Children may be less susceptible, but data is limited.
- The effective reproduction number R_t is below 1 now, but careful monitoring and random testing are needed to avoid a second wave.
- Gradual easing of measures is possible if R_t remains under 1, combined with smart contact tracing and dynamic adjustments.